Afya (AFYA)
NASDAQ:AFYA
Want to see AFYA full AI Analyst Report?
AFYA Stock Chart & Stats
$15.00
$0.11(0.70%)
At close: 4:00 PM EST
$15.00
$0.11(0.70%)
Day’s Range― - ―
52-Week Range$13.00 - $18.53
Previous CloseN/A
Volume36.70K
Average Volume (3M)78.52K
Market Cap
$1.26B
Enterprise Value$8.21B
Total Cash (Recent Filing)$1.32B
Total Debt (Recent Filing)$3.16B
Price to Earnings (P/E)8.3
Beta0.50
Next Earnings
Aug 26, 2026EPS Estimate
0.4Next Dividend Ex-DateN/A
Dividend Yield<0.01%
Share Statistics
EPS (TTM)8.37
Shares Outstanding51,293,550
10 Day Avg. Volume78,346
30 Day Avg. Volume78,516
Financial Highlights & Ratios
PEG Ratio0.63
Price to Book (P/B)1.57
Price to Sales (P/S)2.11
P/FCF Ratio7.37
Enterprise Value/Market Cap6.51
Enterprise Value/Revenue2.18
Enterprise Value/Gross Profit3.39
Enterprise Value/Ebitda4.92
Forecast
1Y Price Target
$19.25Price Target Upside28.33% Upside
Rating ConsensusHold
Number of Analyst Covering2
EPS Forecast (FY)8.94
Revenue Forecast (FY)$4.02B
Bulls Say, Bears Say
Bulls Say
Margin Improvement TrendModest margin expansion following recent trends suggests improving operational efficiency that can enhance profitability as revenue grows.
Organic Revenue Growth Across SegmentsBroad-based organic revenue growth across segments indicates diversified demand that can underpin more stable top-line performance.
Undergraduate Cash GenerationStrong cash generation from undergraduate programs supports the valuation and may sustain shareholder returns while investments continue.
Bears Say
AI Competition Undermining Subscription ModelWhitebook faces strong competition from AI-based medical apps that undercut subscription pricing, risking subscription revenue and user retention.
Non-core Investments Weighing On ReturnsRising investments in non-core businesses are likely to pressure shareholder returns by reallocating cash away from dividends or buybacks.
Slow Ramp Of Medical Practice SolutionsSlower-than-expected ramp of medical practice solutions limits revenue contribution and could delay anticipated earnings improvements.
Afya News
AFYA FAQ
What was Afya’s price range in the past 12 months?
Afya lowest stock price was $13.00 and its highest was $18.53 in the past 12 months.
What is Afya’s market cap?
Afya’s market cap is $1.26B.
When is Afya’s upcoming earnings report date?
Afya’s upcoming earnings report date is Aug 26, 2026 which is in 68 days.
How were Afya’s earnings last quarter?
Afya released its earnings results on May 07, 2026. The company reported $0.562 earnings per share for the quarter, missing the consensus estimate of $0.564 by -$0.003.
Is Afya overvalued?
According to Wall Street analysts Afya’s price is currently Undervalued.
Does Afya pay dividends?
Afya pays a Notavailable dividend of $0.656 which represents an annual dividend yield of <0.01%. See more information on Afya dividends here
What is Afya’s EPS estimate?
Afya’s EPS estimate is 0.4.
How many shares outstanding does Afya have?
Afya has 51,293,550 shares outstanding.
What happened to Afya’s price movement after its last earnings report?
Afya reported an EPS of $0.562 in its last earnings report, missing expectations of $0.564. Following the earnings report the stock price went down -2.18%.
Which hedge fund is a major shareholder of Afya?
Currently, no hedge funds are holding shares in AFYA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Afya Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$19.25 (28.33% Upside)
$19.25 (28.33% Upside)
Blogger Sentiment
Neutral
AFYA Sentiment 50%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 15.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.9M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-3.20%
12-Months-Change
Fundamentals
Return on Equity
16.00%
Trailing 12-Months
Asset Growth
15.87%
Trailing 12-Months
Company Description
Afya
Afya Limited, operating through its subsidiaries, is a prominent medical education provider in Brazil. The company delivers a comprehensive array of educational products and services primarily focused on the medical field, encompassing medical schools, preparatory courses for medical residency, advanced graduate studies, and various other programs tailored for medical professionals at all career stages. These offerings are available across its proprietary network and are also extended to external medical institutions. Beyond traditional education, Afya also offers digital health services through a subscription-based platform, accessible via a mobile app and website. This platform is specifically designed to assist healthcare practitioners and students with clinical decision-making by providing essential tools such as medical calculators, reference charts, up-to-date content, prescription guidance, clinical scoring systems, details on medical procedures, and laboratory examination information. While strong in medicine, Afya's educational portfolio spans a broader spectrum of health sciences, including dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine. Furthermore, the company extends its academic offerings beyond healthcare to include undergraduate and postgraduate degree programs in diverse subjects like business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. The company further enhances its educational ecosystem by providing specialized postgraduate medical programs, both printed and digital educational materials, an online medical learning platform, and hands-on medical training opportunities. As of December 31, 2021, Afya maintained an extensive network of 46 undergraduate and graduate medical school campuses, which included 30 operational undergraduate units and five approved units. This infrastructure supported a total capacity of 2,731 medical school seats, with 2,481 actively operating and an additional 278 seats approved for future use. Established in 1999, Afya Limited is headquartered in Nova Lima, Brazil.
AFYA Company Deck
AFYA Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a strongly positive operational and financial performance for 2025: solid revenue growth (+12% YoY), record-ish margins and profitability metrics, robust cash generation, conservative leverage (0.8x net debt/EBITDA), and an explicit capital return program (dividends and buybacks). Management is pivoting to multi-year investments to integrate products, deepen physician engagement and scale B2B/B2P monetization, which moderates near-term margins and introduces execution and timing risk (e.g., rebuilding Residency Journey, softer MAUs, regulatory uncertainty around ENAMED/ProFMed). Overall, the highlights (growth, cash generation, low leverage, shareholder returns, clear strategy) substantially outweigh the lowlights (segment softness, engagement dip, guidance margin compression and regulatory questions).View all AFYA earnings summariesAFYA Stock 12 Month Forecast
Average Price Target
$19.25
▲(28.33% Upside)
Technical Analysis
Ownership Overview
1.38% Insiders
9.65% Mutual Funds
13.07% Other Institutional Investors
75.44% Public Companies and
Individual Investors